The Epstein–Barr virus (EBV) was discovered 36 years ago by electron microscopy of cells
cultured from Burkitt's lymphoma tissue by Epstein, Achong, and Barr. 1 Four years later, in …

EBV is a prevalent virus, infecting> 90% of the world's population. This is an oncogenic virus
that causes~ 200,000 cancer-related deaths annually. It is, in addition, a significant …

Formation of skeletal elements during embryogenesis and the dynamic remodeling of bone
in the adult involve an exquisite interplay of developmental cues, signaling proteins …

Epstein-Barr virus (EBV) infects and transforms primary B lymphocytes in vitro. Viral infection
initiates the cell cycle entry of the resting B lymphocytes. The maintenance of proliferation in …

Ets is a family of transcription factors present in species ranging from sponges to human. All
family members contain an approximately 85 amino acid DNA binding domain, designated …

Epstein–Barr virus (EBV; human herpesvirus 4; HHV‐4) and Kaposi sarcoma‐associated
herpesvirus (KSHV; human herpesvirus 8; HHV‐8) are human gammaherpesviruses that …

Epstein-Barr virus nuclear antigen 2 (EBNA2) regulation of transcription through the cell
transcription factor RBPJ is essential for resting B-lymphocyte (RBL) conversion to immortal …

Epstein-Barr virus nuclear antigen 2 (EBNA 2) activates transcription of specific genes and is
essential for B-lymphocyte transformation. EBNA 2 has an acidic activation domain which …

Epstein–Barr virus (EBV) transforms B lymphocytes into lymphoblastoid cell lines usurping
the Notch and tumor necrosis factor receptor pathways to effect transcription including NF-κB …

The Epstein–Barr virus (EBV) nuclear protein 2 (EBNA2) and herpes simplex virion protein
16 (VP16) acidic domains that mediate transcriptional activation now are found to have …